Maynard Um
-
-
-
-
-
-
-
Arcturus Therapeutics (ARCT) PT Lowered to $9 at Citi
-
-
-
-
-
-
-
Arcturus Therapeutics (ARCT) PT Lowered to $42 at Wells Fargo
-
-
-
-
-
-
-
Citi Reiterates Buy Rating on Arcturus Therapeutics (ARCT), PT $44, Opens 90-Day Positive Catalyst Watch
-
-
-
-
-
-
-
Arcturus Therapeutics (ARCT) PT Lowered to $68 at Canaccord Genuity
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Arcturus Therapeutics (ARCT)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Arcturus Therapeutics (ARCT)
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Arcturus Therapeutics (ARCT)
-
418,483 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

